Breaking News

Clondalkin Group Appoints CEO

February 4, 2013

Lennon to head global business development plans

David Lennon has been appointed global chief executive officer of the Pharmaceutical and Healthcare Division at Clondalkin Group. Mr. Lennon will head Clondalkin’s global business development plans and will work closely with the European and North American management teams. The division has invested almost $300 million during the past five years and plans to significantly increase the international packaging group’s geographical footprint and expand its current product offering.
 
Mr. Lennon joined the company in 2009 as chief executive officer of the European Pharma and Healthcare division. Mr. Lennon was responsible for the expansion of accredited pharmaceutical packaging facilities from three to eight sites through growth and strategic acquisition.
 
Clondalkin Group chief executive Norbert McDermott said, “We appointed David in 2009 because his pedigree as a senior executive as well as his packaging business expertise was clear.  In his four years with Clondalkin Group he has continued to prove himself to be an invaluable leader in consolidating our position as a leading producer of secondary pharmaceutical packaging where we now operate from 18 sites in North America and Europe. I am delighted to have David heading up the global development strategy of our Pharmaceutical and Healthcare Division and am confident of our continued success.”

Related Contract Manufacturing:

Related Packaging:

blog comments powered by Disqus
  • Staying Ahead in the Small Molecule Space

    Staying Ahead in the Small Molecule Space

    Dr. Matthew Moorcroft, VP Global Marketing, Cambrex||September 8, 2016
    Understand what is happening in the market and react accordingly

  • FDA & Drug Development

    FDA & Drug Development

    Rachelle Du2019Souza, Regulatory Heights Inc.||September 8, 2016
    You must perform the necessary due diligence to stay on top of regulatory developments

  • Patent Law  and Contract Manufacturing

    Patent Law and Contract Manufacturing

    Beverly W. Lubit, Member of the Firm, Chiesa Shahinian & Giantomasi||September 8, 2016
    Analyzing the impact of The Medicines Co. vs. Hospira Inc. decision